Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yozo Nakazawa

Showing results (71-80 of 209) with videos related to

Pageof 21
Sort By:
Pediatric Transplantation|February 12, 2009
Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignanciesRyu Yanagisawa, Yozo Nakazawa, Kazuo Sakashita, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|September 22, 2011
Telecommunication system for children undergoing stem cell transplantationKazumi Higuchi, Yozo Nakazawa, Nobuhiro Sakata, et al.
The Protein Journal|November 18, 2010
Purification, biochemical characterization, and cloning of phospholipase D from Streptomyces racemochromogenes strain 10-3Yozo Nakazawa, Yoshimasa Sagane, Teppei Kikuchi, et al.
Cancer Immunology, Immunotherapy : CII|October 10, 2022
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangementMasaya Suematsu, Shigeki Yagyu, Hideki Yoshida, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytesYozo Nakazawa, Sunandan Saha, Daniel L Galvan, et al.
Journal of the Neurological Sciences|March 25, 2014
Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapseYoshihiko Hidaka, Yuji Inaba, Kazuyuki Matsuda, et al.
Clinical & Translational Immunology|June 14, 2021
A lymphodepleted non-human primate model for the assessment of acute on-target and off-tumor toxicity of human chimeric antigen receptor-T cellsShigeki Yagyu, Hidemi Mochizuki, Kumiko Yamashima, et al.
Pediatric Transplantation|November 11, 2008
Urinary excretion of ganciclovir contributes to improvement of adenovirus-associated hemorrhagic cystitis after allogeneic bone marrow transplantationYozo Nakazawa, Takefumi Suzuki, Tetsuhiro Fukuyama, et al.
Clinical & Translational Immunology|November 30, 2020
Autologous non-human primate model for safety assessment of <i>piggyBac</i> transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptorHirokazu Morokawa, Shigeki Yagyu, Aiko Hasegawa, et al.
Scientific Reports|November 7, 2014
Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignanciesKoichi Hirabayashi, Yozo Nakazawa, Kazuo Sakashita, et al.
Pageof 21

Showing results (71-80 of 209) with videos related to

Sort By:
Pageof 21
Pediatric Transplantation|February 12, 2009
Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignanciesRyu Yanagisawa, Yozo Nakazawa, Kazuo Sakashita, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|September 22, 2011
Telecommunication system for children undergoing stem cell transplantationKazumi Higuchi, Yozo Nakazawa, Nobuhiro Sakata, et al.
The Protein Journal|November 18, 2010
Purification, biochemical characterization, and cloning of phospholipase D from Streptomyces racemochromogenes strain 10-3Yozo Nakazawa, Yoshimasa Sagane, Teppei Kikuchi, et al.
Cancer Immunology, Immunotherapy : CII|October 10, 2022
Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangementMasaya Suematsu, Shigeki Yagyu, Hideki Yoshida, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytesYozo Nakazawa, Sunandan Saha, Daniel L Galvan, et al.
Journal of the Neurological Sciences|March 25, 2014
Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapseYoshihiko Hidaka, Yuji Inaba, Kazuyuki Matsuda, et al.
Clinical & Translational Immunology|June 14, 2021
A lymphodepleted non-human primate model for the assessment of acute on-target and off-tumor toxicity of human chimeric antigen receptor-T cellsShigeki Yagyu, Hidemi Mochizuki, Kumiko Yamashima, et al.
Pediatric Transplantation|November 11, 2008
Urinary excretion of ganciclovir contributes to improvement of adenovirus-associated hemorrhagic cystitis after allogeneic bone marrow transplantationYozo Nakazawa, Takefumi Suzuki, Tetsuhiro Fukuyama, et al.
Clinical & Translational Immunology|November 30, 2020
Autologous non-human primate model for safety assessment of <i>piggyBac</i> transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptorHirokazu Morokawa, Shigeki Yagyu, Aiko Hasegawa, et al.
Scientific Reports|November 7, 2014
Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignanciesKoichi Hirabayashi, Yozo Nakazawa, Kazuo Sakashita, et al.
Pageof 21